Orient Pharma Company Description

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder.

It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules.

The company was founded in 2008 and is based in Taipei, Taiwan.

Orient Pharma Co., Ltd.

Country	Taiwan
Founded	2008
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	173
CEO	Chun-Tong Huang

Contact Details

Address: No. 368, Fu Hsing South Road Taipei, 106 Taiwan
Phone	886 2 2325 7621
Website	oppharma.com

Stock Details

Ticker Symbol	4166
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0004166004
SIC Code	2834

Key Executives

Name	Position
Chun-Tong Huang	General Manager
Yi Xin Zhang	Chief Financial Officer
Zhi Cheng Lu	Chief Operating Officer